Research & Development: Page 64
-
PharmaVoice Team/PharmaVoice
Achieving Value from Discovery and Preclinical Endeavors
The need to increase value and productivity throughout the development process has never been more critical. R&D expenditure continued to drop in 2010 to an estimated three-year low of $68 billion, and drug success rates continue to show the declining trends of the past decade, according to t...
By Denise Myshko • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Molecule to Market - Along the Continuum
According to the most recent report from Tufts Center for the Study of Drug Development, it still takes about 10 to 15 years on average for an experimental drug to travel from the lab to U.S. patients. Only five in 5,000 compounds that enter preclinical testing make it to human testing. Only one ...
By Taren Grom • Feb. 26, 2012 -
Explore the Trendline➔
Getty Images
TrendlineArtificial intelligence & machine learning
After years of excited buzz around the potential of artificial intelligence and machine learning, pharma has begun to realize the true implications and potential value of these technologies.
By PharmaVoice staff -
PharmaVoice Team/PharmaVoice
Talent Pool
Pharmaceutical POOL Dr. Anders EKBLOM Dr. Briggs MORRISON AstraZeneca Bolsters R&D Leadership Global pharmaceutical company AstraZeneca has tapped Anders Ekblom, M.D., to build and lead the science and technology integration office within the company’s R&D organization. In addition to th...
By Carolyn Gretton • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
What's New
New Healthcare-related Products, Services, and Companies Featured Briefs: Kantar Health Focuses on Cancer Patients’ Healthcare Decision-Making Aerpio Therapeutics Makes Debut In other news… Inspiration Biopharmaceuticals Moves Corporate Headquarters AROUND THE GLOBE Kantar Health, a healthcare-fo...
By Carolyn Gretton • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, Marketing, and R&D Trends from Industry Analysts Featured Briefs: Long-Term Planning Tactics Key to Maintaining Portfolio Health Sidebar: Groups Responsible for Aligning Brand and Corporate Strategy Therapeutic Fast Trax… Other market insights… Brand Positioning Should Balance PR, RO...
By Taren Grom • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
Awards… » Invivodata Co-Founder wins Carnegie Science Awards Invivodata Co-founder and Chief Science Officer, Dr. Saul Shiffman has been recognized by the Carnegie Science Center as an honorable mention in the Entrepreneur Category of its 2012 Carnegie Science Awards. Dr. Shiffman is being ...
By Taren Grom • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Letter from the Editor
From Molecule through Market… the vision is clear — to be successful pharmaceutical companies and their valued development partners need to understand the underlying challenges, trends, and opportunities that each molecule, compound, diagnostic, or biotech product faces as it progresses along the...
By Taren Grom • Feb. 26, 2012 -
PharmaVoice Team/PharmaVoice
Outsourcing: Enhance, Support, Grow
You cannot do today’s job with yesterday’s methods and be in business tomorrow." The wise words of Nelson Jackson should be the driving force behind every outsourcing partnership today. Implementing innovative strategies through outsourcing helps pharmaceutical companies meet the changing demands...
By Erin Neary and Dennis McLoughlin • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Commercialization - Decisions, Decisions, Decisions
In recent years, the research and development landscape in the pharmaceutical industry has radically changed. The search for the next big blockbuster has been replaced by the search for medicines targeted toward specific patient subpopulations or toward diseases with high unmet medical need to ma...
By Dr. Michael Ackerman • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Pharmaceutical Call Centers Build relationships with Healthcare Providers and Patients
Pharmaceutical, biotechnology, and medical device companies have a significant need to build relationships with prescribers and patients. However, these audiences have very different needs that require companies to take varying approaches to communicate effectively with them. Healthcare providers...
By Lou Shapiro • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
The Emergence of Strategic Outsourcing in Clinical Supply Chain Management
Ten years ago few biopharmaceutical industry professionals could have predicted how broadly the landscape for outsourcing would change by 2012. Most companies were outsourcing in a tactical, project-by-project manner and utilizing dozens of providers across functional areas. Some were moving to a...
By Robert Dunlop • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Why Outsourcing Patient Enrollment to a Specialist Makes Sense
Richard Malcolm, Ph.D., CEO, Acurian Disruptive change is needed in clinical trial management, an industry where inadequate enrollment has become the biggest driver of wasted dollars. The cost of patient enrollment is now the single largest part of the total trial budget, representing 32% of the ...
By Richard Malcolm • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
SHOWCASE FEATURE: Help from The Outside
Help from the Outside Showcase Feature: Outsourcing Carolyn Gretton As life-sciences companies look to improve operational efficiencies within their organizations, they are increasingly reducing the number of activities that they would categorize as core competencies and outsourcing them to thir...
By Carolyn Gretton • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Trends, Challenges, and Best Practices of Global Product Launches
Companies both large and small are expanding their global launch approach. Robin Robinson With all the variances and complexities involved in launching a product globally, especially around regulatory and approval requirements within various regions across countries, one could argue that there is...
By Robin Robinson • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
C-Suite CROs
Insights from the C-Suite: Contract Research Organizations CRO growth continues to outpace other sectors. Frost &?Sullivan estimates that the CRO market earned revenue of $11.43 billion in 2010 and estimates that the sector will top $20.09 billion in 2017. According to a recent Frost & Su...
By Taren Grom • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Transformative Leadership
Taren Grom Dr. Deborah Dunsire, President and CEO of Millennium: The Takeda Oncology Company, is leading her company to achieve an audacious goal: curing cancer. We are what we repeatedly do…excellence, then, is not so much an act, but a habit." This Aristotle quote is one of Deborah Dunsire, M.D...
By Taren Grom • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Last Word
Creating Jobs in the Industry Safi Bahcall, Ph.D., CEO, Synta Pharmaceuticals, discusses how the extension of the R&D tax credit for life-sciences companies can accelerate job creation. PV: What do you think employment within the industry will look like in 2012? Bahcall: As the U.S. economy...
By Safi Bahcall • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
Talent Pool
executive appointments and promotions in the healthcare industry By Carolyn Gretton Pharmaceutical POOL Aaron BERG Essentialis Names CEO Essentialis, a pharmaceutical company focused on a novel medicine for the treatment of cardiovascular and metabolic disease, has promoted Aaron Berg to CEO, fro...
By Carolyn Gretton • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
PharmaTrax
Sales, marketing, And R&D?Trends affecting the healthcare industry By Carolyn Gretton Life-Sciences Companies Face Increased Complexity in Aggregate Spend Tracking and Reporting Trend: Aggregate spend mandates within the life-sciences industry are continuing to evolve in 2012 amid ongoing cha...
By Carolyn Gretton • Jan. 27, 2012 -
PharmaVoice Team/PharmaVoice
What's New
New healthcare-related products, services, and companies By Carolyn Gretton New Alliance Promotes Trust in Online Physician Research Trend: Market research organizations, which base many critical decisions on insights from online physician panels, are taking collective action to ensure the integ...
By Carolyn Gretton • Jan. 26, 2012 -
PharmaVoice Team/PharmaVoice
UpFront
INDUSTRY at Large Milestones… Spectrum Celebrates 15 Years Spectrum, a health and science communications agency, is celebrating its 15th anniversary. The independent agency, which was founded by John Seng in 1996, is committed to achieving the goals of clients who are involved with issues, pro...
By Taren Grom • Jan. 26, 2012 -
PharmaVoice Team/PharmaVoice
Six Social Shifts: Trends Affecting Pharma Now
Like all things digital, the social media environment is moving so fast that even news from just three months ago seems old. The regulatory environment of pharma exacerbates the challenge to stay ahead of this social world. The pharma industry was anything but an early adopter in the social space...
By Whitney Poma • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Global: R&D Outsourcing
Robin Robinson Outsourcing has always been about cutting costs and creating efficiencies, and today’s pressures have made the R&D process more global than ever. Myriad pressures have the industry looking toward global R&D outsourcing as a life raft in a sea of change. A U.K. report by Del...
By Robin Robinson • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
The Littlest Patients
Denise Myshko Incentives and mandates have spurred drugmakers to test many products in children and to enhance the pediatric information provided on drug labels. But experts say there is still a long way to go to address this specialty population. Over the past 15 years, biopharmaceutical co...
By Denise Myshko • Dec. 22, 2011 -
PharmaVoice Team/PharmaVoice
Pharma 3.0 Next Steps
Robin Robinson Pharma Expands Disease Categories of 3.0 Efforts Between 2006 and 2009, 24% of Pharma 3.0 initiatives focused first on diabetes and metabolics. In 2010, oncology moved to the top with 15% of the year’s initiatives, and diabetes and metabolics tied for second with immunoscience/...
By PharmaVoice Team • Dec. 22, 2011
Previous
